Marex Group’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-6,700
Closed -$529K 1054
2025
Q4
$529K Buy
6,700
+309
+5% +$24.2K ﹤0.01% 549
2025
Q3
$511K Buy
6,391
+2,712
+74% +$231K ﹤0.01% 495
2025
Q2
$334K Buy
3,679
+1,285
+54% +$117K ﹤0.01% 429
2025
Q1
$224K Sell
2,394
-781
-25% -$69.9K ﹤0.01% 554
2024
Q4
$289K Sell
3,175
-1,751
-36% -$167K ﹤0.01% 458
2024
Q3
$511K Buy
4,926
+1,945
+65% +$198K 0.01% 298
2024
Q2
$289K Buy
+2,981
New +$275K 0.01% 426
2024
Q1
Sell
-3,528
Closed -$281K 544
2023
Q4
$281K Buy
+3,528
New +$265K 0.01% 400
2023
Q2
Sell
-3,841
Closed -$289K 245
2023
Q1
$289K Buy
+3,841
New +$286K 0.04% 204

Other funds holding CL

Marex Group's CL Position: Q1 2026 in Review

Marex Group sold out of Colgate-Palmolive (CL) in Q1 2026, closing a stake of 6,700 shares — an estimated $529K sold.

Marex Group first reported a position in CL in Q1 2023 and held it in 9 quarters. The position peaked at $529K in Q4 2025. 1,946 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Marex Group reported no remaining Colgate-Palmolive position as of Q1 2026 after selling out during the quarter.
  • Marex Group sold 6,700 Colgate-Palmolive shares in Q1 2026, an estimated $529K.
  • Marex Group first reported a position in Colgate-Palmolive in Q1 2023 and held it in 9 quarters.
  • Marex Group's Colgate-Palmolive position peaked at $529K in Q4 2025.
  • 1,946 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Marex Group's 13F filing for Q1 2026, filed 13 May 2026.